drugset / Trial / NCT03016793

Alveolar Cleft Grafting Using Two Different Alloplastic Grafts

NCT03016793

Phase 2 Unknown 20 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

P-patients with unilateral alveolar clefts I-purabone with -β-tricalcium phosphate graft C-β-tricalcium phosphate graft alone O-clinical out come Outcome name Measurement device Measurement unit Esthetic satisfaction (Primary outcome) Numerical rating scale(NRS) Number 0-10 Radiographic outcome: Outcome name Measurment Device Measurment unite Bone volume (Secondary out come) (CBCT)machine Cranex 3D Sordex Cubic millimeter Bone Density (Secondary Outcome) (CBCT)machine Cranex 3D Sordex Hounsfield Unite Research Question Would purabone addition to β-tricalcium phosphate be more effective and esthetically satisfying than tricalcium phosphate alone in alveolar cleft grafting?

Timeline

Start
2017-01
Primary completion
2017-06
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Puerarin Small molecule
Background β- tricalcium phosphate Unknown

Indications